HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$68.99
+0.44 (+0.64%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+0.17%
1Y
+30.66%
YTD
-1.88%
Open$69.34
Previous Close$68.55
Day High$69.81
Day Low$68.27
52W High$82.22
52W Low$51.06
Volume—
Avg Volume1.73M
Market Cap8.13B
P/E Ratio23.31
EPS$2.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$71.23
Below
SMA 200
$65.75
Above
RSI (14)
47.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
16 analysts
Price Target
-69.5% upside
Current
$68.99
$68.99
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.34B | 1.04B | 1.30B |
| Net Income | 303.35M | 212.66M | -74,995,325 |
| Profit Margin | 22.7% | 21.6% | -5.8% |
| EBITDA | 517.13M | 382.67M | -91,476,031 |
| Free Cash Flow | — | — | -86,399,966 |
| Rev Growth | +28.4% | +28.4% | +13.4% |
| Debt/Equity | 43.89 | 43.89 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |